Cargando…
The risk for breast cancer is not evidently increased in women with hyperprolactinemia
The question has been raised whether hyperprolactinemia in humans is associated with an excess risk for breast cancer. We aimed to assess the risk of breast cancer in a previously defined large cohort of patients treated for idiopathic hyperprolactinemia or prolactinomas. Based on the pattern of dru...
Autores principales: | Dekkers, O. M., Romijn, J. A., de Boer, A., Vandenbroucke, J. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913002/ https://www.ncbi.nlm.nih.gov/pubmed/20012697 http://dx.doi.org/10.1007/s11102-009-0214-y |
Ejemplares similares
-
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions
por: Johnston, A. N., et al.
Publicado: (2018) -
Hair loss and hyperprolactinemia in women
por: Lutz, Gerhard
Publicado: (2012) -
The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS
por: van der Ham, Kim, et al.
Publicado: (2023) -
Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013) -
Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)